Evidence map›Paper›PMID 41033753›Full record

ArticleBMJ open2025

Time to first optimal glycaemic control and associated factors among adult patients with diabetes at the University of Gondar Comprehensive Specialized Hospital, northwest Ethiopia: a retrospective cohort study.

Adane Desta Getahun, Emneteab Mesfin Ayele, Tilahun Degu Tsega, Sisay Sitotaw Anberbr, Gebremariam Wulie Geremew, Alemneh Ayu Biyazin, Basazinew Mekuria Taye, Gizework Alemnew Mekonnen

Abstract read
In one paragraph

Article in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Adane Desta GetahunDepartment of Clinical Pharmacy, College of Medicine and Health Science, University of Gondar, Gondar, Ethiopia adanedesta87@gmail.com.ORCID http://orcid.org/0009-0008-3604-0385
Emneteab Mesfin AyeleDepartment of Clinical Pharmacy, College of Medicine and Health Science, University of Gondar, Gondar, Ethiopia.
Tilahun Degu TsegaDepartment of Public Health, College of Medicine and Health Science, Injibara University, Injibara, Ethiopia.ORCID http://orcid.org/0000-0002-2388-3171
Sisay Sitotaw AnberbrDepartment of Clinical Pharmacy, College of Medicine and Health Science, University of Gondar, Gondar, Ethiopia.ORCID http://orcid.org/0009-0006-2945-0306
Gebremariam Wulie GeremewDepartment of Clinical Pharmacy, College of Medicine and Health Science, University of Gondar, Gondar, Ethiopia.ORCID http://orcid.org/0009-0000-6691-8568
Alemneh Ayu BiyazinDepartment of Clinical Pharmacy, College of Medicine and Health Science, University of Gondar, Gondar, Ethiopia.
Basazinew Mekuria TayeDepartment of Pharmacy, College of Medicine and Health Science, Injibara University, Injibara, Ethiopia.
Gizework Alemnew MekonnenDepartment of Clinical Pharmacy, College of Medicine and Health Science, University of Gondar, Gondar, Ethiopia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo assess the time to first optimal glycaemic control and its predictors among adult patients with type 1 and type 2 diabetes at the University of Gondar Comprehensive Specialized Hospital in Ethiopia.

designA retrospective cohort study.

settingUniversity of Gondar Comprehensive Specialized Hospital, northwest, Ethiopia.

participantsWe recruited 423 adult diabetic patients who were diagnosed between 1 January 2018 and 30 December 2022 at the University of Gondar Comprehensive Specialized Hospital. OUTCOME MEASURES: The primary outcome was the time from diagnosis to the achievement of the first optimal glycaemic control, measured in months. A Cox proportional hazards regression model was fitted to identify predictors of time to first optimal glycaemic control. Data were collected with KoboToolbox from patient medical charts and exported to Stata V.17. The log-rank test was used to determine the survival difference between subgroups of participants.

resultsMedian time to first optimal glycaemic control was 10.6 months. Among 423 adult diabetic patients, 301 (71.16%) achieved the first optimal glycaemic control during the study period. Age category (middle age (adjusted HR (AHR)=0.56, 95% CI 0.41 to 0.76), older age (AHR=0.52, 95% CI 0.33 to 0.82)), comorbidity (AHR=0.52, 95% CI 0.35 to 0.76), therapeutic inertia (AHR=0.20, 95% CI 0.13 to 0.30) and medication non-compliance (AHR=0.49, 95% CI 0.27 to 0.89) were significant predictors of time to optimal glycaemic control.

conclusionThe median time to first optimal glycaemic control was prolonged. Diabetic care should focus on controlling the identified predictors to achieve optimal glycaemic control early after diagnosis.

Indexed as

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2Glycemic ControlHypoglycemic AgentsTime-to-TreatmentAdultAgedBlood GlucoseEthiopiaFemaleGlycated HemoglobinHospitals, SpecialHumansMaleMiddle AgedProportional Hazards ModelsBlood GlucoseGlycated HemoglobinHypoglycemic AgentsDiabetes & endocrinologyEthiopiaFollow-Up StudiesRetrospective Studies

Identifiers

PMID41033753
PMCPMC12496110

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.